Safest Antidepressants for Older Adults

First-Line Options for Older Adults

Selective Serotonin Reuptake Inhibitors (SSRIs) are generally considered first-line treatment for depression in older adults due to their better adverse effect profiles compared to older antidepressants like tricyclic antidepressants (TCAs) 1, 2
The American Academy of Family Physicians recommends the following as preferred agents for older adults with depression: Sertraline, Citalopram, Escitalopram, Mirtazapine, Venlafaxine, and Bupropion 1, 2, 3

Paroxetine should be avoided due to its higher anticholinergic effects, which can be particularly problematic for older adults 1, 2, 3
Fluoxetine should be avoided due to its long half-life, greater risk of drug interactions, and potential for agitation and overstimulation in older adults 1, 2, 3
Tricyclic antidepressants (TCAs) should be avoided due to their significant anticholinergic effects and are considered potentially inappropriate medications according to the American Geriatric Society's Beers Criteria 1

Follow a "start low, go slow" approach for antidepressant therapy in older adults 1, 3
Start with approximately 50% of the adult starting dose due to older adults' significantly greater risk of adverse drug reactions 1

After a first episode of depression, treatment should continue for 4-12 months after symptom resolution 1, 2
For patients with recurrent depression, longer treatment periods may be beneficial 1, 2
The probability of recurrence increases with each episode (50% after first episode, 70% after second, 90% after third) 1

Regular monitoring for adverse effects is essential, especially during the first few weeks of treatment 3
For older adults taking SSRIs who also require NSAIDs, be aware of the significantly increased risk of upper gastrointestinal bleeding 4, 5

Antidepressants are effective in treating depression in older adults, with studies showing that those who received antidepressants were twice as likely to have remission from depression as those who received placebo 4, 5
For severe depression, antidepressants have shown greater benefit compared to placebo 1, 6

The American Academy of Family Physicians recommends citalopram (20-40 mg/day, maximum 20 mg/day in adults >60 years due to QT prolongation risk) as a preferred option for older adults 7

SSRIs, including sertraline, are associated with clinically significant hyponatremia in elderly patients (0.5-12% incidence), typically occurring within the first month of treatment 7
Citalopram carries a 2012 FDA boxed warning not to exceed 20 mg/day in adults older than 60 years due to dose-dependent QT prolongation 7, 8
SSRIs increase risk of GI bleeding (OR 1.2-1.5), particularly when combined with NSAIDs or antiplatelet drugs 7
Antidepressants are actually protective against suicidality in adults ≥65 years (OR 0.06), unlike younger age groups 7, 8, 9